Investing.com - Ideaya Biosciences reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ideaya Biosciences announced earnings per share of $0.04 on revenue of $29.7M. Analysts polled by Investing.com anticipated EPS of $-0.61 on revenue of $7.97M.
Ideaya Biosciences shares are down 35% from the beginning of the year, still down 26.51% from its 52 week high of $24.71 set on November 22, 2021.
Ideaya Biosciences shares gained 3.30% in intra-day trade following the report.
Ideaya Biosciences follows other major Healthcare sector earnings this month
Ideaya Biosciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar